Original Research
Published on 27 Apr 2020
Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells
in Cancer Immunity and Immunotherapy

- 6,663 views
- 16 citations
Original Research
Published on 27 Apr 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 27 Apr 2020
in Antigen Presenting Cell Biology

Original Research
Published on 27 Apr 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 24 Apr 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 24 Apr 2020
in Inflammation

Review
Published on 24 Apr 2020
in Viral Immunology

Original Research
Published on 24 Apr 2020
in Immunological Tolerance and Regulation

Original Research
Published on 24 Apr 2020
in Inflammation

Review
Published on 24 Apr 2020
in Cancer Immunity and Immunotherapy

Review
Published on 24 Apr 2020
in Cytokines and Soluble Mediators in Immunity

Original Research
Published on 24 Apr 2020
in NK and Innate Lymphoid Cell Biology

Original Research
Published on 24 Apr 2020
in Microbial Immunology

Original Research
Published on 24 Apr 2020
in Molecular Innate Immunity

Review
Published on 24 Apr 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 23 Apr 2020
in Molecular Innate Immunity

Review
Published on 23 Apr 2020
in Vaccines and Molecular Therapeutics
